HQHETF / Fundabrdn Healthcare Investors
Verdicts genuinely change. Free email alert the moment HQH's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
abrdn Healthcare Investors
167 holdings · as of 2026-06-30 (4.7 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
NON-COMPLIANT At least 34.77% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 41% turns out to be. Matching more holdings can only raise this share, never lower it.
167 holdings, 79 matched (59% of weight). Portfolio as of 2026-06-30, filed 2026-08-28. Source: SEC Form N-PORT.
4.86% of this portfolio’s income is non-permissible — weighted across holdings, computed over 43% of portfolio weight (56 of 167 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.
All holdings (167)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| uniQure NV | UNSCREENED | 4.19% | no in-house ratios for this holding |
| VeraDermics Inc | UNSCREENED | 3.41% | no in-house ratios for this holding |
| Insmed Inc | UNSCREENED | 2.80% | no in-house ratios for this holding |
| ARGX Argenx SE | COMPLIANT | 2.48% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VERADERMICS, INC. | UNSCREENED | 2.26% | no in-house ratios for this holding |
| PSNL Personalis Inc | NON_COMPLIANT | 2.17% | AAOIFI2.3% Usmani12.4% Dow Jones Islamic4.6% S&P Shariah6.3% MSCI Islamic12.4% MSCI Islamic M-Series6.3% FTSE Shariah0.0% |
| TECX Tectonic Therapeutic Inc | NON_COMPLIANT | 1.95% | AAOIFI1.0% Usmani1.6% Dow Jones Islamic0.8% S&P Shariah1.0% MSCI Islamic1.6% MSCI Islamic M-Series1.0% FTSE Shariah0.0% |
| Oruka Therapeutics Inc | UNSCREENED | 1.91% | no in-house ratios for this holding |
| ABT Abbott Laboratories | COMPLIANT | 1.83% | AAOIFI16.6% Usmani28.8% Dow Jones Islamic15.7% S&P Shariah16.2% MSCI Islamic28.8% MSCI Islamic M-Series16.2% FTSE Shariah28.8% |
| BCRX BioCryst Pharmaceuticals Inc | NON_COMPLIANT | 1.71% | AAOIFI21.1% Usmani68.8% Dow Jones Islamic21.3% S&P Shariah23.8% MSCI Islamic68.5% MSCI Islamic M-Series23.8% FTSE Shariah66.9% |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 1.63% | AAOIFI20.3% Usmani23.8% Dow Jones Islamic21.8% S&P Shariah19.5% MSCI Islamic23.8% MSCI Islamic M-Series19.5% FTSE Shariah23.8% |
| HUM Humana Inc | NON_COMPLIANT | 1.62% | AAOIFI23.6% Usmani21.8% Dow Jones Islamic36.9% S&P Shariah34.0% MSCI Islamic21.8% MSCI Islamic M-Series34.0% FTSE Shariah21.8% |
| Denali Therapeutics Inc | UNSCREENED | 1.62% | no in-house ratios for this holding |
| AMGN Amgen Inc | COMPLIANT | 1.48% | AAOIFI21.4% Usmani56.2% Dow Jones Islamic31.0% S&P Shariah32.5% MSCI Islamic56.2% MSCI Islamic M-Series32.5% FTSE Shariah56.2% |
| Immunovant Inc | UNSCREENED | 1.47% | no in-house ratios for this holding |
| Abivax SA | UNSCREENED | 1.47% | no in-house ratios for this holding |
| Praxis Precision Medicines Inc | UNSCREENED | 1.46% | no in-house ratios for this holding |
| Crinetics Pharmaceuticals Inc | UNSCREENED | 1.40% | no in-house ratios for this holding |
| EYPT EyePoint Inc | NON_COMPLIANT | 1.28% | AAOIFIfail Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| MDT Medtronic PLC | COMPLIANT | 1.22% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| DHR Danaher Corp | COMPLIANT | 1.21% | AAOIFI16.4% Usmani28.4% Dow Jones Islamic18.0% S&P Shariah16.8% MSCI Islamic28.4% MSCI Islamic M-Series16.8% FTSE Shariah28.4% |
| ISRG Intuitive Surgical Inc | COMPLIANT | 1.21% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| DYN Dyne Therapeutics Inc | NON_COMPLIANT | 1.21% | AAOIFI7.0% Usmani17.7% Dow Jones Islamic9.1% S&P Shariah9.1% MSCI Islamic17.7% MSCI Islamic M-Series9.1% FTSE Shariah16.2% |
| NEUROVANCE MILESTONE INTEREST | UNSCREENED | 1.21% | no in-house ratios for this holding |
| GPCR Structure Therapeutics Inc | NON_COMPLIANT | 1.19% | AAOIFI0.5% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| Newamsterdam Pharma Co NV | UNSCREENED | 1.19% | no in-house ratios for this holding |
| CVS CVS Health Corp | NON_COMPLIANT | 1.18% | AAOIFI66.4% Usmani29.2% Dow Jones Islamic80.4% S&P Shariah85.9% MSCI Islamic29.2% MSCI Islamic M-Series85.9% FTSE Shariah23.5% |
| Edgewise Therapeutics Inc | UNSCREENED | 1.15% | no in-house ratios for this holding |
| RVMDW Revolution Medicines Inc | NON_COMPLIANT | 1.14% | AAOIFI49.8% Usmani14.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic14.9% MSCI Islamic M-Series— FTSE Shariah11.3% |
| Summit Therapeutics Inc | UNSCREENED | 1.14% | no in-house ratios for this holding |
| SRPT Sarepta Therapeutics Inc | NON_COMPLIANT | 1.11% | AAOIFI76.5% Usmani38.2% Dow Jones Islamic31.7% S&P Shariah18.8% MSCI Islamic38.2% MSCI Islamic M-Series18.8% FTSE Shariah32.1% |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 1.06% | AAOIFI16.9% Usmani38.0% Dow Jones Islamic22.0% S&P Shariah21.4% MSCI Islamic38.0% MSCI Islamic M-Series21.4% FTSE Shariah38.0% |
| Xenon Pharmaceuticals Inc | UNSCREENED | 1.05% | no in-house ratios for this holding |
| PODD Insulet Corp | COMPLIANT | 1.03% | AAOIFI9.5% Usmani28.2% Dow Jones Islamic5.6% S&P Shariah6.0% MSCI Islamic28.2% MSCI Islamic M-Series6.0% FTSE Shariah28.2% |
| BSX Boston Scientific Corp | COMPLIANT | 1.02% | AAOIFI18.6% Usmani26.3% Dow Jones Islamic10.0% S&P Shariah10.4% MSCI Islamic26.3% MSCI Islamic M-Series10.4% FTSE Shariah26.3% |
| IMUX IMMUNIC | NON_COMPLIANT | 1.00% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| ELV Elevance Health Inc | NON_COMPLIANT | 1.00% | AAOIFI31.9% Usmani24.1% Dow Jones Islamic38.0% S&P Shariah33.6% MSCI Islamic24.1% MSCI Islamic M-Series33.6% FTSE Shariah24.1% |
| IONS Ionis Pharmaceuticals Inc | NON_COMPLIANT | 1.00% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| CRL Charles River Laboratories International Inc | COMPLIANT | 0.98% | AAOIFI17.7% Usmani38.3% Dow Jones Islamic30.3% S&P Shariah28.5% MSCI Islamic38.3% MSCI Islamic M-Series28.5% FTSE Shariah32.8% |
| State Street Global Advisors | UNSCREENED | 0.93% | no in-house ratios for this holding |
| IDYA Ideaya Biosciences Inc | NON_COMPLIANT | 0.93% | AAOIFI1.0% Usmani2.4% Dow Jones Islamic1.2% S&P Shariah1.1% MSCI Islamic2.4% MSCI Islamic M-Series1.1% FTSE Shariah0.0% |
| SPRY ARS Pharmaceuticals Inc | NON_COMPLIANT | 0.93% | AAOIFI33.2% Usmani48.4% Dow Jones Islamic12.0% S&P Shariah12.4% MSCI Islamic48.4% MSCI Islamic M-Series12.4% FTSE Shariah48.4% |
| NEO NeoGenomics Inc | COMPLIANT | 0.92% | AAOIFI22.5% Usmani32.6% Dow Jones Islamic29.8% S&P Shariah26.9% MSCI Islamic32.2% MSCI Islamic M-Series26.9% FTSE Shariah27.2% |
| VCEL Vericel Corp | COMPLIANT | 0.92% | AAOIFI4.4% Usmani17.6% Dow Jones Islamic4.3% S&P Shariah4.3% MSCI Islamic17.5% MSCI Islamic M-Series4.3% FTSE Shariah0.0% |
| ADPT Adaptive Biotechnologies Corp | COMPLIANT | 0.90% | AAOIFI1.6% Usmani10.8% Dow Jones Islamic3.2% S&P Shariah4.3% MSCI Islamic10.8% MSCI Islamic M-Series4.3% FTSE Shariah0.0% |
| Palvella Therapeutics Inc | UNSCREENED | 0.89% | no in-house ratios for this holding |
| ARWR Arrowhead Pharmaceuticals Inc | COMPLIANT | 0.88% | AAOIFI11.9% Usmani46.3% Dow Jones Islamic12.9% S&P Shariah15.5% MSCI Islamic46.3% MSCI Islamic M-Series15.5% FTSE Shariah39.3% |
| Vaxcyte Inc | UNSCREENED | 0.88% | no in-house ratios for this holding |
| WGS GeneDx Holdings Corp | COMPLIANT | 0.82% | AAOIFI7.1% Usmani27.8% Dow Jones Islamic5.7% S&P Shariah7.7% MSCI Islamic27.8% MSCI Islamic M-Series7.7% FTSE Shariah27.8% |
| JAZZ Jazz Pharmaceuticals PLC | NON_COMPLIANT | 0.82% | AAOIFI36.6% Usmani46.9% Dow Jones Islamic54.5% S&P Shariah60.7% MSCI Islamic46.9% MSCI Islamic M-Series60.7% FTSE Shariah46.4% |
| Disc Medicine Inc | UNSCREENED | 0.78% | no in-house ratios for this holding |
| GRAL GRAIL Inc | NON_COMPLIANT | 0.76% | AAOIFI1.8% Usmani3.1% Dow Jones Islamic3.5% S&P Shariah4.1% MSCI Islamic3.1% MSCI Islamic M-Series4.1% FTSE Shariah0.0% |
| Cogent Biosciences Inc | UNSCREENED | 0.76% | no in-house ratios for this holding |
| MOH Molina Healthcare Inc | NON_COMPLIANT | 0.75% | AAOIFI32.7% Usmani25.2% Dow Jones Islamic31.9% S&P Shariah25.7% MSCI Islamic24.1% MSCI Islamic M-Series25.7% FTSE Shariah24.1% |
| CURASEN THERAPEUTICS, INC. | UNSCREENED | 0.74% | no in-house ratios for this holding |
| OCSAW Oculis Holding AG | NON_COMPLIANT | 0.74% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.0% MSCI Islamic M-Series— FTSE Shariah0.0% |
| CDXS Codexis Inc | NON_COMPLIANT | 0.74% | AAOIFI62.2% Usmani50.1% Dow Jones Islamic33.5% S&P Shariah33.4% MSCI Islamic50.1% MSCI Islamic M-Series33.4% FTSE Shariah28.6% |
| TEM Tempus AI Inc | COMPLIANT | 0.73% | AAOIFI0.7% Usmani3.3% Dow Jones Islamic0.7% S&P Shariah0.8% MSCI Islamic3.3% MSCI Islamic M-Series0.8% FTSE Shariah0.0% |
| ARQT Arcutis Biotherapeutics Inc | COMPLIANT | 0.70% | AAOIFI3.2% Usmani21.9% Dow Jones Islamic4.5% S&P Shariah5.8% MSCI Islamic21.9% MSCI Islamic M-Series5.8% FTSE Shariah20.9% |
| JBIO Jade Biosciences Inc | NON_COMPLIANT | 0.66% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| SION Sionna Therapeutics Inc | NON_COMPLIANT | 0.65% | AAOIFI5.6% Usmani2.9% Dow Jones Islamic0.7% S&P Shariah— MSCI Islamic2.9% MSCI Islamic M-Series— FTSE Shariah0.0% |
| AXSM Axsome Therapeutics Inc | COMPLIANT | 0.63% | AAOIFI2.9% Usmani27.1% Dow Jones Islamic2.8% S&P Shariah3.3% MSCI Islamic25.3% MSCI Islamic M-Series3.3% FTSE Shariah22.7% |
| Mineralys Therapeutics Inc | UNSCREENED | 0.62% | no in-house ratios for this holding |
| IMUX IMMUNIC | NON_COMPLIANT | 0.60% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| Amylyx Pharmaceuticals Inc | UNSCREENED | 0.60% | no in-house ratios for this holding |
| IMUX IMMUNIC INC. | NON_COMPLIANT | 0.59% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| CRBP Corbus Pharmaceuticals Holdings Inc | NON_COMPLIANT | 0.54% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| IMUX Immunic Inc | NON_COMPLIANT | 0.53% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| REGN Regeneron Pharmaceuticals Inc | COMPLIANT | 0.52% | AAOIFI2.0% Usmani6.1% Dow Jones Islamic3.1% S&P Shariah2.7% MSCI Islamic4.5% MSCI Islamic M-Series2.7% FTSE Shariah4.5% |
| RCUS Arcus Biosciences Inc | COMPLIANT | 0.51% | AAOIFI4.9% Usmani14.2% Dow Jones Islamic5.6% S&P Shariah6.2% MSCI Islamic14.2% MSCI Islamic M-Series6.2% FTSE Shariah12.5% |
| HOTSPOT THERAPEUTICS, INC. | UNSCREENED | 0.51% | no in-house ratios for this holding |
| INSP Inspire Medical Systems Inc | COMPLIANT | 0.48% | AAOIFI1.7% Usmani3.0% Dow Jones Islamic0.9% S&P Shariah0.7% MSCI Islamic3.0% MSCI Islamic M-Series0.7% FTSE Shariah0.0% |
| IQV IQVIA Holdings Inc | NON_COMPLIANT | 0.48% | AAOIFI37.4% Usmani53.5% Dow Jones Islamic48.0% S&P Shariah44.6% MSCI Islamic53.5% MSCI Islamic M-Series44.6% FTSE Shariah52.7% |
| DXCM Dexcom Inc | COMPLIANT | 0.47% | AAOIFI4.4% Usmani22.3% Dow Jones Islamic4.6% S&P Shariah4.0% MSCI Islamic21.5% MSCI Islamic M-Series4.0% FTSE Shariah19.9% |
| RYTM Rhythm Pharmaceuticals Inc | NON_COMPLIANT | 0.46% | AAOIFI1.3% Usmani24.0% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic24.0% MSCI Islamic M-Series2.3% FTSE Shariah23.2% |
| ICLR ICON PLC | COMPLIANT | 0.46% | AAOIFI22.8% Usmani21.6% Dow Jones Islamic26.9% S&P Shariah20.7% MSCI Islamic21.6% MSCI Islamic M-Series20.7% FTSE Shariah20.8% |
| IMUX IMMUNIC INC. | NON_COMPLIANT | 0.46% | AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| LENZ LENZ Therapeutics Inc | NON_COMPLIANT | 0.44% | AAOIFI0.4% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.2% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| TSHA Taysha Gene Therapies Inc | NON_COMPLIANT | 0.42% | AAOIFI3.9% Usmani12.5% Dow Jones Islamic5.1% S&P Shariah6.4% MSCI Islamic12.5% MSCI Islamic M-Series6.4% FTSE Shariah10.9% |
| KRYS Krystal Biotech Inc | NON_COMPLIANT | 0.41% | AAOIFI0.1% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| CYTK Cytokinetics Inc | NON_COMPLIANT | 0.39% | AAOIFI7.3% Usmani29.6% Dow Jones Islamic7.7% S&P Shariah8.0% MSCI Islamic29.6% MSCI Islamic M-Series8.0% FTSE Shariah22.9% |
| THIRD ARC BIO, INC | UNSCREENED | 0.37% | no in-house ratios for this holding |
| ACHC Acadia Healthcare Co Inc | NON_COMPLIANT | 0.37% | AAOIFI71.6% Usmani45.1% Dow Jones Islamic101.6% S&P Shariah65.1% MSCI Islamic45.1% MSCI Islamic M-Series65.1% FTSE Shariah42.3% |
| WAT Waters Corp | COMPLIANT | 0.36% | AAOIFI10.7% Usmani20.1% Dow Jones Islamic17.9% S&P Shariah19.8% MSCI Islamic20.1% MSCI Islamic M-Series19.8% FTSE Shariah18.6% |
| MCK McKesson Corp | COMPLIANT | 0.36% | AAOIFI9.5% Usmani12.9% Dow Jones Islamic12.6% S&P Shariah14.0% MSCI Islamic12.9% MSCI Islamic M-Series14.0% FTSE Shariah10.8% |
| MAZE Maze Therapeutics Inc | COMPLIANT | 0.35% | AAOIFI3.3% Usmani11.7% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic11.7% MSCI Islamic M-Seriesfail FTSE Shariah7.6% |
| SpyGlass Pharma Inc | UNSCREENED | 0.35% | no in-house ratios for this holding |
| AgomAb Therapeutics NV | UNSCREENED | 0.35% | no in-house ratios for this holding |
| ELOX ELOXX PHARMACEUTICALS, INC. | NON_COMPLIANT | 0.34% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.0% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ZTS Zoetis Inc | NON_COMPLIANT | 0.33% | AAOIFI28.0% Usmani61.2% Dow Jones Islamic16.9% S&P Shariah14.7% MSCI Islamic61.2% MSCI Islamic M-Series14.7% FTSE Shariah60.0% |
| ASND Ascendis Pharma A/S | COMPLIANT | 0.33% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Definium Therapeutics Inc | UNSCREENED | 0.33% | no in-house ratios for this holding |
| GLYCOMINE, INC. | UNSCREENED | 0.31% | no in-house ratios for this holding |
| CRYSTALYS THERAPEUTICS SER A | UNSCREENED | 0.29% | no in-house ratios for this holding |
| TNDM Tandem Diabetes Care Inc | NON_COMPLIANT | 0.28% | AAOIFI61.9% Usmani63.5% Dow Jones Islamic53.6% S&P Shariah43.9% MSCI Islamic63.5% MSCI Islamic M-Series43.9% FTSE Shariah52.0% |
| QUELL THERAPEUTICS | UNSCREENED | 0.27% | no in-house ratios for this holding |
| ELOX Eloxx Pharmaceuticals Inc | NON_COMPLIANT | 0.27% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.0% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ALLO Allogene Therapeutics Inc | NON_COMPLIANT | 0.27% | AAOIFI26.5% Usmani15.0% Dow Jones Islamic17.8% S&P Shariah16.2% MSCI Islamic15.0% MSCI Islamic M-Series16.2% FTSE Shariah0.0% |
| ALKS Alkermes PLC | COMPLIANT | 0.27% | AAOIFI19.9% Usmani35.4% Dow Jones Islamic27.5% S&P Shariah29.8% MSCI Islamic35.4% MSCI Islamic M-Series29.8% FTSE Shariah33.8% |
| ASMB Assembly Biosciences Inc | NON_COMPLIANT | 0.26% | AAOIFI0.5% Usmani0.7% Dow Jones Islamic0.7% S&P Shariah1.0% MSCI Islamic0.7% MSCI Islamic M-Series1.0% FTSE Shariah0.0% |
| Relay Therapeutics Inc | UNSCREENED | 0.25% | no in-house ratios for this holding |
| QLARIS BIO, INC. | UNSCREENED | 0.25% | no in-house ratios for this holding |
| ARBOR BIOTECHNOLOGIES | UNSCREENED | 0.25% | no in-house ratios for this holding |
| VRTX Vertex Pharmaceuticals Inc | COMPLIANT | 0.25% | AAOIFI4.6% Usmani19.8% Dow Jones Islamic5.5% S&P Shariah5.6% MSCI Islamic19.8% MSCI Islamic M-Series5.6% FTSE Shariah13.7% |
| MOBI Mobia Medical Inc | NON_COMPLIANT | 0.24% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.6% MSCI Islamic M-Series— FTSE Shariah0.0% |
| SKYHAWK THERAPEUTICS, INC. | UNSCREENED | 0.23% | no in-house ratios for this holding |
| ENDEAVOR BIOMEDICINES, INC. | UNSCREENED | 0.23% | no in-house ratios for this holding |
| SEISMIC THERAPEUTICS, INC. | UNSCREENED | 0.21% | no in-house ratios for this holding |
| WVE WaVe Life Sciences Ltd | NON_COMPLIANT | 0.19% | AAOIFI6.1% Usmani8.5% Dow Jones Islamic3.0% S&P Shariah3.5% MSCI Islamic8.5% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| NUVIG THERAPEUTICS, INC | UNSCREENED | 0.19% | no in-house ratios for this holding |
| AMOLYT MILESTONE | UNSCREENED | 0.19% | no in-house ratios for this holding |
| SERA Sera Prognostics Inc | NON_COMPLIANT | 0.18% | AAOIFI4.1% Usmani4.1% Dow Jones Islamic3.6% S&P Shariah2.5% MSCI Islamic4.1% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| BDX Becton Dickinson & Co | NON_COMPLIANT | 0.18% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| Seaport Therapeutics Inc | UNSCREENED | 0.18% | no in-house ratios for this holding |
| ENGRAIL THERAPEUTICS INC. SERI | UNSCREENED | 0.17% | no in-house ratios for this holding |
| HOTSPOT THERAPEUTICS, INC. | UNSCREENED | 0.15% | no in-house ratios for this holding |
| INFINANT HEALTH | UNSCREENED | 0.14% | no in-house ratios for this holding |
| ATALANTA THERAPEUTICS | UNSCREENED | 0.13% | no in-house ratios for this holding |
| EVMN EVOMMUNE | NON_COMPLIANT | 0.12% | AAOIFI2.5% Usmani2.9% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic2.7% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| ATALANTA THERAPEUTICS | UNSCREENED | 0.12% | no in-house ratios for this holding |
| INVETX MILESTONE INTEREST | UNSCREENED | 0.12% | no in-house ratios for this holding |
| INCENDIA THERAPEUTICS, INC. | UNSCREENED | 0.12% | no in-house ratios for this holding |
| CURASEN THERAPEUTICS, INC. | UNSCREENED | 0.11% | no in-house ratios for this holding |
| THC Tenet Healthcare Corp | NON_COMPLIANT | 0.11% | AAOIFI61.3% Usmani41.9% Dow Jones Islamic79.9% S&P Shariah88.7% MSCI Islamic41.9% MSCI Islamic M-Series88.7% FTSE Shariah41.9% |
| ARBOR BIOTECHNOLOGIES | UNSCREENED | 0.10% | no in-house ratios for this holding |
| InspireMD Inc | UNSCREENED | 0.09% | no in-house ratios for this holding |
| KLRA Kailera Therapeutics Inc | NON_COMPLIANT | 0.08% | AAOIFI0.6% Usmani0.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.9% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ABCURO, INC. | UNSCREENED | 0.08% | no in-house ratios for this holding |
| ODTX Odyssey Therapeutics Inc | NON_COMPLIANT | 0.08% | AAOIFI2.5% Usmani5.4% Dow Jones Islamic— S&P Shariah— MSCI Islamic5.4% MSCI Islamic M-Series— FTSE Shariah0.0% |
| CURASEN THERAPEUTICS CONV PN | UNSCREENED | 0.08% | no in-house ratios for this holding |
| RECODE THERAPEUTICS | UNSCREENED | 0.08% | no in-house ratios for this holding |
| ENDEAVOR BIOMEDICINES INC. | UNSCREENED | 0.06% | no in-house ratios for this holding |
| Avalyn Pharma Inc | UNSCREENED | 0.06% | no in-house ratios for this holding |
| HOTSPOT THERAPEUTICS, INC. | UNSCREENED | 0.05% | no in-house ratios for this holding |
| ABCURO INC. | UNSCREENED | 0.05% | no in-house ratios for this holding |
| HIBERCELL,INC. SERIES C | UNSCREENED | 0.05% | no in-house ratios for this holding |
| HIBERCELL INC. | UNSCREENED | 0.05% | no in-house ratios for this holding |
| HIBERCELL BRIDGE NOTE | UNSCREENED | 0.05% | no in-house ratios for this holding |
| Hemab Therapeutics Holdings Inc | UNSCREENED | 0.05% | no in-house ratios for this holding |
| Incendia Therapeutics, Inc. | UNSCREENED | 0.05% | no in-house ratios for this holding |
| Options Clearing Corp. | UNSCREENED | 0.05% | no in-house ratios for this holding |
| HIBERCELL, INC. SERIES B | UNSCREENED | 0.04% | no in-house ratios for this holding |
| INCENDIA THERAPEUTICS, INC. | UNSCREENED | 0.04% | no in-house ratios for this holding |
| BIOTHERYX, INC. SERIES E | UNSCREENED | 0.04% | no in-house ratios for this holding |
| AVICEDA THERAPEUTICS | UNSCREENED | 0.04% | no in-house ratios for this holding |
| HIBERCELL, INC. | UNSCREENED | 0.03% | no in-house ratios for this holding |
| QLARIS BIO, INC. | UNSCREENED | 0.03% | no in-house ratios for this holding |
| CURASEN THERAPEUTICS, INC. | UNSCREENED | 0.03% | no in-house ratios for this holding |
| OCULIS HOLDINGS AG | UNSCREENED | 0.02% | no in-house ratios for this holding |
| QLARIS BIO BRIDGE NOTE | UNSCREENED | 0.02% | no in-house ratios for this holding |
| Options Clearing Corp. | UNSCREENED | 0.01% | no in-house ratios for this holding |
| RECODE THERAPEUTICS, INC. | UNSCREENED | 0.01% | no in-house ratios for this holding |
| INCENDIA BRIDGE NOTE 5/2026 | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Options Clearing Corp. | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CONTRA CHINOOK THERAPE | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CONTRA FUSION PHARMACE | UNSCREENED | 0.00% | no in-house ratios for this holding |
| TWST Twist Bioscience Corp | COMPLIANT | 0.00% | AAOIFI1.1% Usmani13.9% Dow Jones Islamic3.2% S&P Shariah3.5% MSCI Islamic13.9% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| IO LIGHT HOLDINIGS, INC. | UNSCREENED | 0.00% | no in-house ratios for this holding |
| PRIOTHERA LIMITED | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Willow Laboratories Inc. | UNSCREENED | 0.00% | no in-house ratios for this holding |
| HIBERCELL INC. | UNSCREENED | 0.00% | no in-house ratios for this holding |
| HIBERCELL, INC. SERIES C | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Afferent Milestone Interest | UNSCREENED | 0.00% | no in-house ratios for this holding |
| ETHISMOS RESEARCH, INC. MILEST | UNSCREENED | 0.00% | no in-house ratios for this holding |
| AMPHIVENA MILESTONE INTEREST | UNSCREENED | 0.00% | no in-house ratios for this holding |
| RECODE THERAPEUTICS, INC. | UNSCREENED | 0.00% | no in-house ratios for this holding |
| HIBERCELL INC. | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 16 points of portfolio weight — 27.4% of it passes Dow Jones Islamic, 11.5% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 24.8% ratios fail on 29.5% 45.8% not rated under AAOIFI
ratios pass on 18.2% ratios fail on 36.8% 45.1% not rated under Usmani
ratios pass on 27.4% ratios fail on 23.3% 49.5% not rated under Dow Jones Islamic
ratios pass on 27.4% ratios fail on 21.0% 51.8% not rated under S&P Shariah
ratios pass on 11.5% ratios fail on 42.5% 46.2% not rated under MSCI Islamic
ratios pass on 26.9% ratios fail on 22.7% 50.6% not rated under MSCI Islamic M-Series
ratios pass on 18.6% ratios fail on 36.5% 45.1% not rated under FTSE Shariah
74 of 167 listed holdings carry our own per-methodology verdicts (59% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 68 (53% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| PSNL Personalis Inc | 2.17% |
| TECX Tectonic Therapeutic Inc | 1.95% |
| BCRX BioCryst Pharmaceuticals Inc | 1.71% |
| UNH UnitedHealth Group Inc | 1.63% |
| HUM Humana Inc | 1.62% |
| EYPT EyePoint Inc | 1.28% |
| DYN Dyne Therapeutics Inc | 1.21% |
| GPCR Structure Therapeutics Inc | 1.19% |
| CVS CVS Health Corp | 1.18% |
| RVMDW Revolution Medicines Inc | 1.14% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
abrdn Healthcare Investors (HQH) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for HQH — this runs off the critical path so the page paints first. It will appear here on its own.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Israel Englander | Millennium Management | $1M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 46.30 | NEUTRAL |
| Stochastic %K (14) | 35.06 | NEUTRAL |
| CCI (20) | -65.17 | NEUTRAL |
| Williams %R (14) | -64.94 | NEUTRAL |
| MACD (12,26,9) | -0.06 | SELL |
| ROC (10) | -4.54 | SELL |
| Momentum (10) | -0.98 | SELL |
| EMA (10) | 21.07 | SELL |
| SMA (10) | 21.20 | SELL |
| EMA (20) | 20.98 | SELL |
| SMA (20) | 21.07 | SELL |
| EMA (30) | 20.93 | SELL |
| SMA (30) | 20.55 | BUY |
| EMA (50) | 20.94 | SELL |
| SMA (50) | 20.74 | SELL |
| EMA (100) | 20.78 | SELL |
| SMA (100) | 21.34 | SELL |
| EMA (200) | 19.68 | BUY |
| SMA (200) | 19.82 | BUY |
About abrdn Healthcare Investors
Financial Services · Asset Management
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | RANGING | 43 |
| ⏰ 4H | RANGING | 34 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | RANGING | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.